Literature DB >> 11748152

Deficiency of phospholipase C-gamma1 impairs renal development and hematopoiesis.

M Shirane1, H Sawa, Y Kobayashi, T Nakano, K Kitajima, Y Shinkai, K Nagashima, I Negishi.   

Abstract

Phospholipase C-gamma1 (PLC-gamma1) is involved in a variety of intracellular signaling via many growth factor receptors and T-cell receptor. To explore the role of PLC-gamma1 in vivo, we generated the PLC-gamma1-deficient (plc-gamma1(-/-)) mice, which died of growth retardation at embryonic day 8.5-9.5 in utero. Therefore, we examined plc-gamma1(-/-) chimeric mice generated with plc-gamma1(-/-) embryonic stem (ES) cells for further study. Pathologically, plc-gamma1(-/-) chimeras showed multicystic kidney due to severe renal dysplasia and renal tube dilation. Flow cytometric analysis and glucose phosphate isomerase assay revealed very few hematopoietic cells derived from the plc-gamma1(-/-) ES cells in the mutant chimeras. However, differentiation of plc-gamma1(-/-) ES cells into erythrocytes and monocytes/macrophages in vitro was observed to a lesser extent compared with control wild-type ES cells. These data suggest that PLC-gamma1 plays an essential role in the renal development and hematopoiesis in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11748152     DOI: 10.1242/dev.128.24.5173

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  11 in total

Review 1.  To bud or not to bud: the RET perspective in CAKUT.

Authors:  T Keefe Davis; Masato Hoshi; Sanjay Jain
Journal:  Pediatr Nephrol       Date:  2014-04       Impact factor: 3.714

2.  Independent roles of Fgfr2 and Frs2alpha in ureteric epithelium.

Authors:  Sunder Sims-Lucas; Brian Cusack; Veraragavan P Eswarakumar; Jue Zhang; Fen Wang; Carlton M Bates
Journal:  Development       Date:  2011-02-24       Impact factor: 6.868

3.  Critical and distinct roles for key RET tyrosine docking sites in renal development.

Authors:  Sanjay Jain; Mario Encinas; Eugene M Johnson; Jeffrey Milbrandt
Journal:  Genes Dev       Date:  2006-02-01       Impact factor: 11.361

Review 4.  Lipid signaling in T-cell development and function.

Authors:  Yina H Huang; Karsten Sauer
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-10-13       Impact factor: 10.005

5.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

6.  Phospholipase Cγ2 is required for basal but not oestrogen deficiency-induced bone resorption.

Authors:  Zsuzsanna Kertész; Dávid Gyori; Szandra Körmendi; Tünde Fekete; Katalin Kis-Tóth; Zoltán Jakus; Georg Schett; Eva Rajnavölgyi; Csaba Dobó-Nagy; Attila Mócsai
Journal:  Eur J Clin Invest       Date:  2011-07-12       Impact factor: 4.686

7.  Autonomous Calcium Signaling in Human and Zebrafish Podocytes Controls Kidney Filtration Barrier Morphogenesis.

Authors:  Lydia Djenoune; Ritu Tomar; Aude Dorison; Irene Ghobrial; Heiko Schenk; Jan Hegermann; Lynne Beverly-Staggs; Alejandro Hidalgo-Gonzalez; Melissa H Little; Iain A Drummond
Journal:  J Am Soc Nephrol       Date:  2021-04-28       Impact factor: 14.978

Review 8.  Emerging roles of PLCγ1 in endothelial biology.

Authors:  Dongying Chen; Michael Simons
Journal:  Sci Signal       Date:  2021-08-03       Impact factor: 8.192

9.  Preferential Propagation of Competent SIX2+ Nephronic Progenitors by LIF/ROCKi Treatment of the Metanephric Mesenchyme.

Authors:  Shunsuke Tanigawa; Nirmala Sharma; Michael D Hall; Ryuichi Nishinakamura; Alan O Perantoni
Journal:  Stem Cell Reports       Date:  2015-08-28       Impact factor: 7.765

10.  Rescue of hematopoietic stem/progenitor cells formation in plcg1 zebrafish mutant.

Authors:  Karine F Ferri-Lagneau; Jamil Haider; Shengmin Sang; TinChung Leung
Journal:  Sci Rep       Date:  2019-01-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.